Joint Accreditation Statement

In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA Credit Designation

Practicing Clinicians Exchange designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation

NP course advisor: Mary Knudtson, DNSc, NP, FAAN, University of California, Irvine, Irvine, California.
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until March 30, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Lawrence Herman, DMSc, MPA, PA-C, University of Lynchburg, Lynchburg, Virginia

IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

This program is cosupported by educational grants from Alcon Vision, LLC; Biohaven Pharmaceuticals; Genentech, a member of the Roche Group; Gilead Sciences, Inc.; and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Auwaerter: consulting fees: Adaptive Biotherapeutics, EMD Serono, Humanigen, Verily; consulting fees/contracted research: Pfizer; ownership interest: Johnson & Johnson.

Dr Herman: fees for non-CME/CE services: Novo Nordisk.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Herman as noted above.

Participants wishing to earn CE/CME credit must:

1. Review the content in its entirety
2. Relate the content material to the learning objectives
3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.

The estimated time to complete this activity is 1.00 hour.

Release date: March 31, 2022
Expiration date: March 30, 2023

For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.